Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 79,130 shares at $88.94 ($7.0M) on 2023-05-09, disclosed to the SEC on 2023-05-09.
Scheduled sale ($7.0M) by CVP, Critical Care under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.74 | 2,154 | $191K | 2.7% |
| 2 | $88.74 | 1,376 | $122K | 1.7% |
| 3 | $88.94 | 75,600 | $6.7M | 95.5% |
| Total | $88.93 avg | 79,130 | $7.0M | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |